SCHEMBL29709363

SCHEMBL29709363

COc1cc(O)c2c(c1O)C(=O)c1cc(C)cc(O)c1C2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 3/20 0.69
▸ ELANE P08246 4/20 0.61
▸ MAPT P10636 4/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ KDM4E B2RXH2 3/20 0.61
▸ ALOX15 P16050 2/20 0.61
▸ GLA P06280 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ ACLY P53396 9/20 0.58
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ EPHX2 P34913 3/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ TSHR P16473 2/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ PTP4A3 O75365 1/20 0.55
▸ GMNN O75496 1/20 0.55
▸ LMNA P02545 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19303812 0.91 ELANE (0.65) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL16226994 0.85 ELANE (0.66) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL29361502 0.85 ELANE (0.66) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL29359746 0.85 ELANE (0.66) PIM1ELANEMAPTALDH1A1KDM4E
Austrocortirubin SCHEMBL23199031 0.84 LCK (0.56) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL23199095 0.84 ALDH1A1 (0.60) PIM1ELANEMAPTALDH1A1KDM4E
Austrocortirubin SCHEMBL29357393 0.84 LCK (0.56) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL23199046 0.82 PIM1 (0.66) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL23198975 0.82 EPHX2 (0.65) PIM1ELANEMAPTALDH1A1KDM4E
SCHEMBL30097984 0.82 ACLY (0.71) PIM1ELANEMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11304927-B2 Bioactive extract, fraction of Cassia occidentalis and formulation thereof for bone regeneration COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2022-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11304927-B2 Bioactive extract, fraction of Cassia occidentalis and formulation thereof for bone regeneration BMP4, BMP2, BMP1 PIM1 2182/4885ELANE 4141/4885MAPT 4399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback